The Secaucus, NJ-based company joins a long list of medtech and healthcare companies that have faced cyberattacks in 2026.

Abbott CEO Robert Ford explains how LAA and diabetes pressures drove Q3 guidance cuts, and what's ahead for 2027 growth.

Qiagen's run as a publicly traded company may be nearing its end. The molecular testing company announced that it has agreed to an all-cash takeover from Swedish private equity firm EQT in a deal that ...

As screen time climbs and blue-violet light exposure becomes an unavoidable part of daily life, contact lens wearers are placing new demands on their eyes, and on the lenses they wear. Johnson & ...

Following the premiere of You Can See Everything, a panel of women from the medtech industry unpacked the complicated, ...

Designing, testing, and certifying home healthcare devices for safe, reliable use beyond the clinical environment.

Successful micro-sensor integration is critical to designing devices that drive revolutionary medical innovations.

The move follows a wave of similar divestitures across medtech as companies streamline portfolios and sharpen focus on higher-growth segments.

FDA issues an import alert on Japan-made Olympus endoscopy devices, citing unresolved quality violations following a recent warning letter.

EY's 2026 Pulse report shows AI shifting medtech value from devices to the algorithms, data, and digital services that power them.